Xencor
The Scientist 2 will join Xencor's Antibody Discovery team to develop and optimize yeast‑display platforms, design and construct antibody libraries, and conduct in‑vitro display campaigns to identify and improve therapeutic candidates. The role involves collaborating across functional groups, analyzing NGS data, and contributing to lead optimization and experimental strategy.
Headquarters
Pasadena, California, United States
Company Size
201-500 employees
Founded
1997
Xencor is a clinical-stage biopharmaceutical company that designs engineered proteins to create novel biologic medicines. Using proprietary protein-design platforms (including XmAb Fc engineering and cytokine/antibody engineering), Xencor builds next‑generation monoclonal antibodies, bispecifics and cytokine therapeutics with improved potency, half‑life and safety. The company advances an internal pipeline across oncology and immune‑mediated diseases while partnering with other biopharma organizations to discover and develop therapeutics. Xencor emphasizes rational protein design and translational science to deliver differentiated medicines to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Xencor.
71% above the average for this role
Principal Scientist, Biotherapeutics Discovery, Antibody Generation
Digital Biology
Senior Scientist
AstraZeneca
Principal Scientist, Biotherapeutics Discovery, Antibody Generation
Digital Biology
Scientist Antibody Discovery
Global Channel Management
Molecular Biologist (R6 – R7)
Eli Lilly and Company
Scientist , Antibody Engineering
Twist Bioscience